Literature DB >> 10888597

Increased levels of apoptosis in the prefusion neural folds underlie the craniofacial disorder, Treacher Collins syndrome.

J Dixon1, C Brakebusch, R Fässler, M J Dixon.   

Abstract

Treacher Collins syndrome (TCS) is an autosomal dominant disorder of human craniofacial development that results from loss-of-function mutations in the gene TCOF1. Although this gene has been demonstrated to encode the nucleolar phosphoprotein treacle, the developmental mechanism underlying TCS remains elusive, particularly as expression studies have shown that the murine orthologue, Tcof1, is widely expressed. To investigate the molecular pathogenesis of TCS, we replaced exon 1 of Tcof1 with a neomycin-resistance cassette via homologous recombination in embryonic stem cells. Tcof1 heterozygous mice die perinatally as a result of severe craniofacial anomalies that include agenesis of the nasal passages, abnormal development of the maxilla, exencephaly and anophthalmia. These defects arise due to a massive increase in the levels of apoptosis in the prefusion neural folds, which are the site of the highest levels of Tcof1 expression. Our results demonstrate that TCS arises from haploinsufficiency of a protein that plays a crucial role in craniofacial development and indicate that correct dosage of treacle is essential for survival of cephalic neural crest cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10888597     DOI: 10.1093/hmg/9.10.1473

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  39 in total

1.  Learning cell biology as a team: a project-based approach to upper-division cell biology.

Authors:  Robin Wright; James Boggs
Journal:  Cell Biol Educ       Date:  2002

Review 2.  Craniofacial birth defects: The role of neural crest cells in the etiology and pathogenesis of Treacher Collins syndrome and the potential for prevention.

Authors:  Paul A Trainor
Journal:  Am J Med Genet A       Date:  2010-08-23       Impact factor: 2.802

3.  Macular degeneration associated with a novel Treacher Collins tcof1 mutation and evaluation of this mutation in age related macular degeneration.

Authors:  S V Goverdhan; I K Temple; J Self; A J Lotery; M J Dixon; A R Evans
Journal:  Br J Ophthalmol       Date:  2005-08       Impact factor: 4.638

Review 4.  Diamond-Blackfan anemia: diagnosis, treatment, and molecular pathogenesis.

Authors:  Jeffrey M Lipton; Steven R Ellis
Journal:  Hematol Oncol Clin North Am       Date:  2009-04       Impact factor: 3.722

Review 5.  Rare syndromes of the head and face: mandibulofacial and acrofacial dysostoses.

Authors:  Karla Terrazas; Jill Dixon; Paul A Trainor; Michael J Dixon
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2017-02-10       Impact factor: 5.814

6.  Treacher Collins Syndrome : A Report on Two Cases.

Authors:  A K Dubey; R K Gupta
Journal:  Med J Armed Forces India       Date:  2011-07-21

7.  The Treacher Collins syndrome (TCOF1) gene product is involved in ribosomal DNA gene transcription by interacting with upstream binding factor.

Authors:  Benigno C Valdez; Dale Henning; Rolando B So; Jill Dixon; Michael J Dixon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

Review 8.  Molecular basis of cleft palates in mice.

Authors:  Noriko Funato; Masataka Nakamura; Hiromi Yanagisawa
Journal:  World J Biol Chem       Date:  2015-08-26

9.  Reduced transcription of TCOF1 in adult cells of Treacher Collins syndrome patients.

Authors:  Cibele Masotti; Camila C Ornelas; Alessandra Splendore-Gordonos; Ricardo Moura; Têmis M Félix; Nivaldo Alonso; Anamaria A Camargo; Maria Rita Passos-Bueno
Journal:  BMC Med Genet       Date:  2009-12-14       Impact factor: 2.103

10.  A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q- syndrome.

Authors:  Jillian L Barlow; Lesley F Drynan; Duncan R Hewett; Luke R Holmes; Silvia Lorenzo-Abalde; Alison L Lane; Helen E Jolin; Richard Pannell; Angela J Middleton; See Heng Wong; Alan J Warren; James S Wainscoat; Jacqueline Boultwood; Andrew N J McKenzie
Journal:  Nat Med       Date:  2009-11-22       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.